Clinical Trial Update: Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating weekly Taxotere (docetaxel) with Iressa (gefitinib) or placebo in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Iressa (gefitinib)
• Taxotere (docetaxel)

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED